MAPS Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill expands a appropriation, compliance mandate provision: 2. Essential Medicines List The Secretary, in coordination with the heads of other relevant Federal departments and agencies and in consultation with, reduces a reporting req, compliance mandate, definition change provision: 3, and expands a appropriation, reporting req, compliance mandate provision: 4. U.S. pharmaceutical supply chains mapping. It relies on compliance mandates, appropriations, reporting requirements, and definition changes. The main policy areas are Healthcare.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Expands a appropriation, compliance mandate provision: 2. Essential Medicines List The Secretary, in coordination with the heads of other relevant Federal departments and agencies and in consultation with...
- Reduces a reporting req, compliance mandate, definition change provision: 3.
- Expands a appropriation, reporting req, compliance mandate provision: 4. U.S. pharmaceutical supply chains mapping.
- Adds or tightens a reporting req, compliance mandate provision: 5. Department of Defense biannual reports.
- Expands a appropriation, compliance mandate provision: 7. Additional provisions The participation of the Secretary in developing and updating the list of essential medicines under section 2 shall be deemed to be full...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill expands a appropriation, compliance mandate provision: 2. Essential Medicines List The Secretary, in coordination with the heads of other relevant Federal departments and agencies and in consultation with, reduces a reporting req, compliance mandate, definition change provision: 3, and expands a appropriation, reporting req, compliance mandate provision: 4. U.S. pharmaceutical supply chains mapping.
Key Policy Areas
Healthcare
Primary Purpose
The bill expands a appropriation, compliance mandate provision: 2. Essential Medicines List The Secretary, in coordination with the heads of other relevant Federal departments and agencies and in consultation with, reduces a reporting req, compliance mandate, definition change provision: 3, and expands a appropriation, reporting req, compliance mandate provision: 4. U.S. pharmaceutical supply chains mapping.
Policy Domains
Sponsors
Legislative Progress
In CommitteeCommittee on Health, Education, Labor, and Pensions. Hearings held.
Mr. Peters (for himself, Mr. Lankford, Ms. Ernst, Mr. Cotton, …
Read twice and referred to the Committee on Health, Education, …
Introduced in Senate
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_defense"
- → Secretary of Defense
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology